Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis.

Amram O, Socías E, Nosova E, Kerr T, Wood E, DeBeck K, Hayashi K, Fairbairn N, Montaner J, Milloy MJ.

Spat Spatiotemporal Epidemiol. 2019 Aug;30:100288. doi: 10.1016/j.sste.2019.100288. Epub 2019 Jul 4.

PMID:
31421798
2.

Characterising the association between positive hepatitis C virus antibody and pain among people who inject drugs.

Ng M, Hayashi K, Voon P, Shulha HP, DeBeck K, Milloy MJ, Ti L.

Drug Alcohol Rev. 2019 Aug 16. doi: 10.1111/dar.12969. [Epub ahead of print]

PMID:
31418953
3.

Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.

Pilarinos A, Barker B, Nosova E, Milloy MJ, Hayashi K, Wood E, Kerr T, DeBeck K.

Addiction. 2019 Aug 4. doi: 10.1111/add.14769. [Epub ahead of print]

PMID:
31379008
4.

Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

Mohd Salleh NA, Fairbairn N, Nolan S, Barrios R, Shoveller J, Richardson L, Milloy MJ.

HIV Med. 2019 Jul 29. doi: 10.1111/hiv.12777. [Epub ahead of print]

PMID:
31359615
5.

Trajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996-2017: growth mixture modeling using data from prospective cohort studies.

Dong H, Hayashi K, Singer J, Milloy MJ, DeBeck K, Wood E, Kerr T.

Addiction. 2019 Jul 22. doi: 10.1111/add.14756. [Epub ahead of print]

PMID:
31328354
6.

Characterizing Men Who Have Sex with Men and Use Injection Drugs in Vancouver, Canada.

Scheim A, Knight R, Shulha H, Nosova E, Hayashi K, Milloy MJ, Kerr T, DeBeck K.

AIDS Behav. 2019 Jul 20. doi: 10.1007/s10461-019-02605-6. [Epub ahead of print]

PMID:
31327107
7.

Factors associated with willingness to wear an electronic overdose detection device.

Ahamad K, Dong H, Johnson C, Hyashi K, DeBeck K, Milloy MJ, Wood E.

Addict Sci Clin Pract. 2019 Jul 3;14(1):23. doi: 10.1186/s13722-019-0153-5.

8.

Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.

Ickowicz S, Salleh NAM, Fairbairn N, Richardson L, Small W, Milloy MJ.

AIDS Behav. 2019 Jun 24. doi: 10.1007/s10461-019-02547-z. [Epub ahead of print]

PMID:
31236749
9.

Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada.

Moallef S, Nosova E, Milloy MJ, DeBeck K, Fairbairn N, Wood E, Kerr T, Hayashi K.

Public Health Rep. 2019 Jul/Aug;134(4):423-431. doi: 10.1177/0033354919857084. Epub 2019 Jun 18.

PMID:
31211644
10.

Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.

Irvine MA, Kuo M, Buxton JA, Balshaw R, Otterstatter M, Macdougall L, Milloy MJ, Bharmal A, Henry B, Tyndall M, Coombs D, Gilbert M.

Addiction. 2019 Sep;114(9):1602-1613. doi: 10.1111/add.14664. Epub 2019 Jun 28.

PMID:
31166621
11.

The relationship between childhood emotional abuse and chronic pain among people who inject drugs in Vancouver, Canada.

Prangnell A, Voon P, Shulha H, Nosova E, Shoveller J, Milloy MJ, Kerr T, Hayashi K.

Child Abuse Negl. 2019 Jul;93:119-127. doi: 10.1016/j.chiabu.2019.05.006.

PMID:
31103834
12.

Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: A ten-year prospective cohort study.

Reddon H, Fast D, DeBeck K, Werb D, Hayashi K, Wood E, Milloy MJ.

Int J Drug Policy. 2019 Jul;69:16-23. doi: 10.1016/j.drugpo.2019.02.006. Epub 2019 Apr 20.

PMID:
31015080
13.

Employment Cessation, Long Term Labour Market Engagement and HIV Infection Risk Among People Who Inject Drugs in an Urban Canadian Setting.

Richardson L, Mammel M, Milloy MJ, Hayashi K.

AIDS Behav. 2019 Mar 28. doi: 10.1007/s10461-019-02472-1. [Epub ahead of print]

PMID:
30924066
14.

Opioid agonist treatment and the process of injection drug use initiation.

Mittal ML, Jain S, Sun S, DeBeck K, Milloy MJ, Hayashi K, Hadland SE, Werb D.

Drug Alcohol Depend. 2019 Apr 1;197:354-360. doi: 10.1016/j.drugalcdep.2018.12.018. Epub 2019 Jan 22.

PMID:
30922483
15.

Awareness and Understanding of HIV Non-disclosure Case Law and the Role of Healthcare Providers in Discussions About the Criminalization of HIV Non-disclosure Among Women Living with HIV in Canada.

Patterson S, Nicholson V, Milloy MJ, Ogilvie G, Hogg RS, Carter A, Li T, Ding E, Sereda P, Greene S, de Pokomandy A, Loutfy M, Kaida A; CHIWOS Research Team.

AIDS Behav. 2019 Mar 21. doi: 10.1007/s10461-019-02463-2. [Epub ahead of print]

PMID:
30900043
16.

Patterns of social determinants of health associated with drug use among women living with HIV in Canada: a latent class analysis.

Shokoohi M, Bauer GR, Kaida A, Logie CH, Lacombe-Duncan A, Milloy MJ, Lloyd-Smith E, Carter A, Loutfy M; CHIWOS Research Team.

Addiction. 2019 Jul;114(7):1214-1224. doi: 10.1111/add.14566. Epub 2019 Mar 12.

PMID:
30698902
17.

High Prevalence of Self-Reported Exposure to Adulterated Drugs Among People Who Experienced an Opioid Overdose in Canada: A Cohort Study.

Prangnell A, Fairgrieve C, Nosova E, DeBeck K, Milloy MJ, Hayashi K.

Subst Use Misuse. 2019;54(6):980-985. doi: 10.1080/10826084.2018.1555257. Epub 2019 Jan 20.

PMID:
30663484
18.

Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.

Socías ME, Ti L, Wood E, Nosova E, Hull M, Hayashi K, Debeck K, Milloy MJ.

Liver Int. 2019 Aug;39(8):1400-1407. doi: 10.1111/liv.14043. Epub 2019 Feb 24.

PMID:
30653809
19.

Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs.

Reddon H, Marshall BDL, Milloy MJ.

Lancet HIV. 2019 Feb;6(2):e128-e136. doi: 10.1016/S2352-3018(18)30292-3. Epub 2018 Dec 14. Review.

PMID:
30558843
20.

Gender differences in the provision of injection initiation assistance: a comparison of three North American settings.

Meyers SA, Scheim A, Jain S, Sun X, Milloy MJ, DeBeck K, Hayashi K, Garfein RS, Werb D.

Harm Reduct J. 2018 Dec 4;15(1):59. doi: 10.1186/s12954-018-0270-6.

21.

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P.

Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.

22.

Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.

Bozinoff N, DeBeck K, Milloy MJ, Nosova E, Fairbairn N, Wood E, Hayashi K.

Drug Alcohol Depend. 2018 Dec 1;193:42-47. doi: 10.1016/j.drugalcdep.2018.09.003. Epub 2018 Oct 6.

PMID:
30340144
23.

The relationship between parental heavy drinking and non-fatal overdose among people who inject drugs in Vancouver, Canada.

Prangnell A, Nosova E, Milloy MJ, Wood E, Hayashi K.

Addict Behav. 2019 Feb;89:224-228. doi: 10.1016/j.addbeh.2018.08.016. Epub 2018 Aug 15.

PMID:
30326463
24.

Predictors of Antiretroviral Adherence Self-efficacy Among People Living With HIV/AIDS in a Canadian Setting.

Lee WK, Milloy MJS, Nosova E, Walsh J, Kerr T.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):103-109. doi: 10.1097/QAI.0000000000001878.

PMID:
30300214
25.

Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs.

Barker B, Adams E, Wood E, Kerr T, DeBeck K, Dong H, Shoveller J, Montaner J, Milloy MJ.

AIDS Behav. 2019 May;23(5):1258-1266. doi: 10.1007/s10461-018-2226-y.

PMID:
30269233
26.

Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.

Lo A, Kerr T, Hayashi K, Milloy MJ, Nosova E, Liu Y, Fairbairn N.

J Subst Abuse Treat. 2018 Nov;94:41-46. doi: 10.1016/j.jsat.2018.08.009. Epub 2018 Aug 23.

PMID:
30243416
27.

High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Socías ME, Wood E, Lake S, Nolan S, Fairbairn N, Hayashi K, Shulha HP, Liu S, Kerr T, Milloy MJ.

Addiction. 2018 Dec;113(12):2250-2258. doi: 10.1111/add.14398. Epub 2018 Sep 20.

PMID:
30238568
28.

Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.

Ladak F, Socias E, Nolan S, Dong H, Kerr T, Wood E, Montaner J, Milloy MJ.

Antivir Ther. 2019;24(1):19-25. doi: 10.3851/IMP3265.

PMID:
30230474
29.

Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Socias ME, Milloy MJ.

Curr Infect Dis Rep. 2018 Jul 31;20(9):36. doi: 10.1007/s11908-018-0636-7. Review.

30.

Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada.

Vipler S, Hayashi K, Milloy MJ, Wood E, Nosova E, Kerr T, Ti L.

Subst Abuse Treat Prev Policy. 2018 Jul 5;13(1):27. doi: 10.1186/s13011-018-0164-3.

31.

Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada.

Young S, Wood E, Milloy MJ, DeBeck K, Dobrer S, Nosova E, Kerr T, Hayashi PhD K.

Subst Abus. 2018;39(4):461-468. doi: 10.1080/08897077.2018.1485128. Epub 2018 Oct 2.

PMID:
29949450
32.

Childhood Trauma and the Inability to Access Hospital Care Among People who Inject Drugs.

Randhawa G, Azarbar A, Dong H, Milloy MJ, Kerr T, Hayashi K.

J Trauma Stress. 2018 Jun;31(3):383-390. doi: 10.1002/jts.22286. Epub 2018 Jun 20.

33.

Linking opioid-induced hyperalgesia and withdrawal-associated injury site pain: a case report.

Rieb LM, Norman WV, Martin RE, Berkowitz J, Wood E, Milloy MJ, McNeil R.

Pain Rep. 2018 Apr 5;3(3):e648. doi: 10.1097/PR9.0000000000000648. eCollection 2018 May.

34.

Attrition Across the HIV Cascade of Care Among a Diverse Cohort of Women Living With HIV in Canada.

Kerkerian G, Kestler M, Carter A, Wang L, Kronfli N, Sereda P, Roth E, Milloy MJ, Pick N, Money D, Webster K, Hogg RS, de Pokomandy A, Loutfy M, Kaida A.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):226-236. doi: 10.1097/QAI.0000000000001775.

PMID:
29916960
35.

Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.

Socías ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E, Montaner J, Milloy MJ.

Drug Alcohol Depend. 2018 Aug 1;189:90-95. doi: 10.1016/j.drugalcdep.2018.04.026. Epub 2018 May 29.

36.

Access to medical cannabis is expanding across North America regardless of the opioid crisis-why not study if it could help?

Lake S, Milloy MJ.

Addiction. 2018 Aug;113(8):1550-1551. doi: 10.1111/add.14236. Epub 2018 Jun 7. No abstract available.

PMID:
29882263
37.

Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada.

Cortina S, Kennedy MC, Dong H, Fairbairn N, Hayashi K, Milloy MJ, Kerr T.

Drug Alcohol Rev. 2018 Jul;37(5):645-652. doi: 10.1111/dar.12815. Epub 2018 Jun 5.

38.

HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.

Beaulieu T, Hayashi K, Milloy MJ, Nosova E, DeBeck K, Montaner J, Kerr T, Ti L.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):93-98. doi: 10.1097/QAI.0000000000001651.

39.

Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada.

Klimas J, Nosova E, Socías E, Nolan S, Brar R, Hayashi K, Milloy MJ, Kerr T, Wood E.

Drug Alcohol Depend. 2018 May 1;186:182-186. doi: 10.1016/j.drugalcdep.2018.01.027. Epub 2018 Mar 23.

40.

The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.

Ti L, Socías ME, Wood E, Milloy MJ, Nosova E, DeBeck K, Kerr T, Hayashi K.

PLoS One. 2018 Mar 26;13(3):e0194162. doi: 10.1371/journal.pone.0194162. eCollection 2018.

41.

A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.

Mohd Salleh NA, Richardson L, Kerr T, Shoveller J, Montaner J, Kamarulzaman A, Milloy MJ.

J Addict Med. 2018 Jul/Aug;12(4):308-314. doi: 10.1097/ADM.0000000000000403.

42.

Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis.

Reddon H, DeBeck K, Socias ME, Dong H, Wood E, Montaner J, Kerr T, Milloy MJ.

Drug Alcohol Rev. 2018 Mar;37(3):421-428. doi: 10.1111/dar.12667. Epub 2018 Feb 12.

43.

Residential eviction predicts initiation of or relapse into crystal methamphetamine use among people who inject drugs: a prospective cohort study.

Damon W, McNeil R, Milloy MJ, Nosova E, Kerr T, Hayashi K.

J Public Health (Oxf). 2019 Mar 1;41(1):36-45. doi: 10.1093/pubmed/fdx187.

PMID:
29425315
44.

Patterns of Non-injection Drug Use Associated with Injection Cessation among Street-Involved Youth in Vancouver, Canada.

Lake S, Kerr T, Nosova E, Milloy MJ, Wood E, DeBeck K.

J Urban Health. 2018 Apr;95(2):267-277. doi: 10.1007/s11524-017-0225-3.

45.

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.

Klimas J, Dong H, Fairbairn N, Socías E, Barrios R, Wood E, Kerr T, Montaner J, Milloy MJ.

Addict Sci Clin Pract. 2018 Feb 7;13(1):3. doi: 10.1186/s13722-017-0104-y.

46.

Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada.

Beaulieu T, Ti L, Milloy MJ, Nosova E, Wood E, Hayashi K.

Subst Abuse Treat Prev Policy. 2018 Jan 19;13(1):3. doi: 10.1186/s13011-018-0142-9.

47.

Increasing diversion of methadone in Vancouver, Canada, 2005-2015.

Reddon H, Ho J, DeBeck K, Milloy MJ, Liu Y, Dong H, Ahamad K, Wood E, Kerr T, Hayashi K.

J Subst Abuse Treat. 2018 Feb;85:10-16. doi: 10.1016/j.jsat.2017.11.010. Epub 2017 Nov 28.

48.

Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.

Hayashi K, Dong H, Kerr T, Dobrer S, Guillemi S, Barrios R, Montaner JSG, Wood E, Milloy MJ.

J Infect Dis. 2017 Dec 27;217(1):64-68. doi: 10.1093/infdis/jix459.

49.

Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.

Hayashi K, Milloy MJ, Lysyshyn M, DeBeck K, Nosova E, Wood E, Kerr T.

Drug Alcohol Depend. 2018 Feb 1;183:1-6. doi: 10.1016/j.drugalcdep.2017.10.020. Epub 2017 Dec 6.

50.

Do law enforcement interactions reduce the initiation of injection drug use? An investigation in three North American settings.

Melo JS, Garfein RS, Hayashi K, Milloy MJ, DeBeck K, Sun S, Jain S, Strathdee SA, Werb D.

Drug Alcohol Depend. 2018 Jan 1;182:67-73. doi: 10.1016/j.drugalcdep.2017.10.009. Epub 2017 Nov 16.

Supplemental Content

Loading ...
Support Center